530 results on '"Kühn, Thorsten"'
Search Results
2. Operative Therapie des Mammakarzinoms: „One size does not fit all“: Aktuelle Standards und neue Entwicklungen
3. Targeted axillary dissection: worldwide variations in clinical practice
4. Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
5. Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study
6. Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study
7. Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery
8. Operative Therapie der Axilla – Ist weniger mehr?
9. Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey
10. Awareness, offer, and use of psychosocial services by breast cancer survivors in Germany: a prospective multi-centre study
11. Association of social service counseling in breast cancer patients with financial problems, role functioning and employment—results from the prospective multicenter BRENDA II study
12. Quality assessment of radiotherapy in the prospective randomized SENOMAC trial
13. False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy
14. Management der Axilla 2022: Wann und wie operieren wir noch?
15. Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy—results from the prospective multi-center BRENDA II study
16. Idiopathic Granulomatous Mastitis as a Benign Condition Mimicking Inflammatory Breast Cancer: Current Status, Knowledge Gaps and Rationale for the GRAMAREG Study (EUBREAST-15).
17. Die Sentinel-Lymphknoten-Biopsie beim Mammakarzinom – was haben wir in den letzten 20 Jahren gelernt?
18. Lymphknotenstaging beim Mammakarzinom – Beginn der Bedeutungslosigkeit?
19. AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2024
20. Breast-conserving surgery is not associated with increased local recurrence in patients with early-stage node-negative triple-negative breast cancer treated with neoadjuvant chemotherapy
21. Frühes Mammakarzinom: Aktuelle Strategien in der System- und Radiotherapie: 17. Internationale St.-Gallen-Konsensuskonferenz vor dem Hintergrund deutscher Therapieempfehlungen diskutiert
22. Quality assessment of radiotherapy in the prospective randomized SENOMAC trial
23. „Targeted axillary dissection“ – Standard oder noch experimentell?
24. Spatial location of local recurrences after mastectomy: a systematic review
25. Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project
26. Real de-escalation or escalation in disguise?
27. Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy
28. Systemische Therapie von prämenopausalen Patientinnen mit hormonrezeptorpositivem, HER2-negativem Brustkrebs in den Frühstadien – Kontroversen und Standards in der Krankenversorgung.
29. Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study
30. Supplementary Figure S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
31. Supplementary Table S2 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
32. Data from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
33. Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials
34. Supplementary Appendix S1 from Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer
35. Deep Learning to Predict Breast Cancer Sentinel Lymph Node Status on INSEMA Histological Images
36. Locoregional Therapy: From Mastectomy to Reconstruction, Targeted Surgery, and Ultra-Hypofractionated Radiotherapy
37. Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials
38. Leitlinienkonformität in Brustzentren zur Vermeidung von Unter- und Übertherapien
39. Elderly and Patients with Large Breast Volume Have an Increased Risk of Seroma Formation after Mastectomy—Results of the SerMa Pilot Study
40. The Lucerne Toolbox 2 to optimise axillary management for early breast cancer: a multidisciplinary expert consensus
41. Axillary surgery in the case of limited involved axillary lymph nodes
42. Uncertainties and controversies in axillary management of patients with breast cancer
43. Axilläre Operationen im Wandel der Zeit
44. S3-Leitlinie Mammakarzinom: lokoregionäre Therapie
45. Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
46. Surgical therapy of the axilla—is less more?
47. Th2/Th17 cell associated cytokines found in seroma fluids after breast cancer surgery
48. Abstract OT1-08-01: AXSANA – EUBREAST3: An international prospective multicenter cohort study to evaluate different surgical methods of axillary staging in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy
49. Abstract PD15-06: PD15-06 Pathologic complete response and breast-conserving surgery are associated with improved prognosis in patients with early-stage triple-negative breast cancer treated with neoadjuvant chemotherapy
50. Abstract OT3-20-04: SerMa – Seroma formations of the Mammary gland in breast cancer patients after mastectomy and implant-based reconstruction (EUBREAST 5)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.